KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Gross Margin (2016 - 2026)

Medtronic's Gross Margin history spans 13 years, with the latest figure at 63.83% for Q1 2026.

  • For Q1 2026, Gross Margin fell 265.0% year-over-year to 63.83%; the TTM value through Jan 2026 reached 64.86%, down 41.0%, while the annual FY2025 figure was 65.32%, 3.0% down from the prior year.
  • Gross Margin for Q1 2026 was 63.83% at Medtronic, down from 65.84% in the prior quarter.
  • Across five years, Gross Margin topped out at 68.32% in Q1 2022 and bottomed at 63.83% in Q1 2026.
  • The 5-year median for Gross Margin is 65.42% (2023), against an average of 65.68%.
  • The largest annual shift saw Gross Margin skyrocketed 203bps in 2022 before it tumbled -312bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 66.57% in 2022, then fell by -2bps to 65.42% in 2023, then fell by -1bps to 64.94% in 2024, then rose by 1bps to 65.84% in 2025, then fell by -3bps to 63.83% in 2026.
  • Per Business Quant, the three most recent readings for MDT's Gross Margin are 63.83% (Q1 2026), 65.84% (Q4 2025), and 65.02% (Q3 2025).